According to Zealand Pharma's latest financial reports the company has NZ$2.07 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | NZ$2.03 B | 432.15% |
2023-12-31 | NZ$0.38 B | 43.15% |
2022-12-31 | NZ$0.26 B | -16.08% |
2021-12-31 | NZ$0.31 B | 10.49% |
2020-12-31 | NZ$0.28 B | -1.91% |
2019-12-31 | NZ$0.29 B | 10.92% |
2018-12-31 | NZ$0.26 B | 75.72% |
2017-12-31 | NZ$0.15 B | 128% |
2016-12-31 | NZ$66.09 M | -26.3% |
2015-12-31 | NZ$89.67 M | -16.77% |
2014-12-31 | NZ$0.10 B | 53.98% |
2013-12-31 | NZ$69.96 M | -33.18% |
2012-12-31 | NZ$0.10 B | 9.68% |
2011-12-31 | NZ$95.46 M | -4.68% |
2010-12-31 | NZ$0.10 B | 159.28% |
2009-12-31 | NZ$38.63 M | -43.71% |
2008-12-31 | NZ$68.62 M | 7.12% |
2007-12-31 | NZ$64.06 M |